ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACRM Acuity Rm Group Plc

2.00
0.00 (0.00%)
03 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Acuity Rm Group Plc LSE:ACRM London Ordinary Share GB00BR0WHY71 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.00 1.90 2.10 2.05 2.00 2.00 1,331,428 11:20:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Lessors Of Real Property,nec 1.37M -1.34M -0.0110 -1.82 2.43M

Acuity RM Group Plc - Half-year Report

16/09/2024 7:00am

UK Regulatory


Acuity Rm (LSE:ACRM)
Historical Stock Chart


From Sep 2024 to Dec 2024

Click Here for more Acuity Rm Charts.
Acuity RM Group Plc - Half-year Report

PR Newswire

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

16 September 2024

Acuity RM Group plc 

('ACRM' or the 'Company’ or the “Group”)

Interim Results to 30 June 2024

Acuity RM Group plc (AIM:ACRM), which owns Acuity Risk Management Limited (“Acuity”), today releases the interim results for the six months ended 30 June 2024 (“H1 2024” or the “Period”).

 

Highlights for the Group for the Period:

            Revenues: £1.0m (H1 2023 actual for six months: £0.9m) (£0.347m from the date of acquisition)

            Cash balance: £1.86m (31 December 2023: £0.1m)

            New orders: up 21% to £0.733m (30 June 2023: £0.608m)

            Sales pipeline: £7.9m (30 June 2023: £4.4m)

            Partners: c.25 per cent. of the pipeline is partner sourced. New partners appointed include BSI Group UK, and Sopra Steria.  Acuity now has 15 active partners in North America, the United Kingdom and Europe 

            New product: STORM, counter terrorism risk management software has been launched

            Board changes: Kate Buchan was appointed to the board as Finance Director

 

Angus Forrest, Chairman, commented: “The business has made progress over the past six months as evidenced by the increase in revenues and value of new orders compared with 2023.  Acuity’s management is ambitious and has been taking steps to accelerate the rate of growth which is being supported by the successful fundraise completed in June.”

 

 

 

 

For further information please contact:

 

Acuity RM Group plc

https://www.acuityrmgroup.com

Angus Forrest

+44 (0) 20 3582 0566

Zeus Capital Limited (NOMAD & Broker)

https://www.zeuscapital.co.uk

Mike Coe / Sarah Mather

+44 (0) 20 3829 5000

Peterhouse Capital (Joint broker)

 

Lucy Williams / Duncan Vasey

+44 (0) 20 7469 0936

Clear Capital (Joint broker)

 

Bob Roberts

+44 (0) 20 3869 6080


Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform collects and analyses data about organisations to improve business decisions and management.  It is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

The Company is focused on delivering long term, sustainable growth in shareholder value. In the short to medium term this is expected to come from organic growth and thereafter may also come from complementary acquisitions.

 

 

 

 

 

 

Chairman’s statement

 

I am pleased to present the results of Acuity RM Group plc for the six month period ended 30 June 2024.

The Group has continued to make good progress in the Period, winning new business, securing new partners and developing the Group’s infrastructure and capability. In June 2024 the Company completed a fundraising to raise gross proceeds of c. £1.0m to fund an acceleration in the development of the business.  This fundraise has strengthened the Group’s cash position which as at 30 June 2024 was £1.86m (31 December 2023: £0.1m).

The Company's strategic aim remains unchanged, being to increase revenues, particularly recurring revenues, to generate cash and profits and so drive shareholder value.

 

Financial overview

For the Period the Group reported revenue of £1.0m, an operating loss of £634k and a loss after tax of £590k.

In the Period, whilst the Group won orders valued at over £733k (H1 2023: £608k), it is disappointing that there were few new large orders to announce because the larger opportunities have been complex and are taking longer to convert.  Importantly, annual recurring revenue continues to build and was £900k for the half year to 30 June 2024 (6 months to June 2023: £806k). Total forward contracted revenues as at 30 June 2024 stood at £3.107m (31 December 2023: £2.900m).

The sales pipeline as at 30 June 24 was £7.9m (£4.4m 30 June 2023).

As referenced above, in June 2024, the Company successfully raised £1.0m (before expenses) from new and existing Shareholders. The Board is pleased to have received support from its shareholders as well as having a number of new institutional shareholders invest in the group alongside the executive directors.

 

Operational overview

During the Period, the Group has strengthened the marketing team and launched a campaign to enhance the Group’s position as a leading risk management company in the governance risk and compliance (“GRC”) market. The initiative aims to better communicate the value of the Group’s offerings with changing market needs.

 

The Group has expanded its sales structure during the Period by recruiting experienced senior business development managers with a background in the GRC market. Additionally, the Group has recruited new partners to help increase sales in the UK, North America and Europe.

 

The Group’s award-winning STREAM® is a GRC software platform, which analyses data about organisations to improve business decisions and management. It is used by organisations including government, utilities, defence, broadcasting, manufacturing and healthcare. Most customers use it for managing cybersecurity and IT risks and for compliance with ISO 27001 and other standards and regulations. STREAM® is sold on a SaaS or private cloud delivery (on-premise) basis, typically with a three year licence, invoiced annually in advance. Sales are made direct through the Company's own sales team and via a growing network of partners in the UK, the US and Europe.  The Group is working on a major redevelopment of STREAM® to enhance the product’s technical abilities and user experience.

In April 2024, the Group launched a new product, STORM. STORM is designed to address the emerging market for managing risk assessment at venues and public events, particularly those with a capacity of 800 or more. The Directors believe there is a significant opportunity for this product, as anticipated legislative requirements should drive demand, making STORM a crucial addition to the Group’s portfolio.

 

Board

Kate Buchan, who joined the Company at the end of November 2023, has been appointed to the boards of the Company and Acuity as Finance Director.  Kate has over 25 years of experience as a chartered accountant, having worked in head office finance functions for Lloyds Banking Group and Credit Suisse.

 

Outlook

There is much work to do to enable the Company to achieve its targets and potential. The Board is implementing programmes to improve (1) marketing and sales ability to seize upcoming growth opportunities and (2) the products to broaden and strengthen their appeal. Looking forward, the Board is confident that its initiatives will deliver benefits and drive growth. I would like to thank the shareholders, the staff, my colleagues on the Board and the Company’s advisers for their continuing support.

 

Angus Forrest

Chairman

Condensed consolidated statement of comprehensive income

For the 6 months ended 30 June 2024

 

 

 

Notes

Unaudited 6 months to 30 June 2024

Unaudited 6 months to 30 June 20231

Audited 12 months to December1 2023

 

 

£’000

£’000

£’000

 

 

 

 

 

Revenue

5

1,049

347

1,366

Cost of sales

 

(103)

(33)

(112)

Gross profit

 

946

314

1,254

 

 

 

 

 

Administrative expenses

 

(1,533)

(649)

(2,167)

 

 

 

 

 

Operating loss

 

(586)

(335)

(913)

 

 

 

 

 

Finance - net expense

 

(11)

(1)

(19)

Loss on investments

 

(36)

(73)

(66)

Share based payments expense

 

-

25

(61)

Exceptional Costs

 

-

-

(282)

Loss for the period before taxation

 

(634)

(384)

(1,341)

 

Tax

 

44

-

-

Loss for the period after taxation

 

(590)

(384)

(1,341)

 

 

 

 

 

Basic and diluted (loss) per share from loss for the period

4

(0.48)p

(0.55)p

(1.39)p

 

1 The comparatives include the results of the subsidiary, Acuity Risk Management Limited, from date of acquisition, 25 April 2023.

 

 

 

 

 

 

Condensed consolidated statement of financial position

For the 6 months ended 30 June 2024

 

 

 

Notes

Unaudited 6 months to 30 June 2024

Unaudited 6 months to 30 June 2023

Audited 12 months to December 2023

 

 

£’000

£’000

£’000

Non current assets

 

 

 

 

Intangible assets

 

5,315

6,204

5,387

Tangible assets

6

10

10

8

Investments at fair value through profit or loss

8

207

232

244

Total non current assets

 

5,532

6,446

5,639

 

 

 

 

 

Current assets

 

 

 

 

Trade and other receivables

 

324

678

1,255

Cash and cash equivalents

 

1,855

493

100

Total current assets

 

2,179

1,171

1,355

 

 

 

 

 

Total assets

 

7,711

7,617

6,994

 

 

 

 

 

Current and long term liabilities

 

 

 

 

Trade, other payables and loans

 

858

568

876

Deferred income

 

2,403

1,406

2,030

Total liabilities

 

3,261

1,974

2,906

 

 

 

 

 

Net assets

 

4,450

5,643

4,088

 

 

 

 

 

Equity

 

 

 

 

Share capital

7

2,796

2,767

2,767

Share premium

 

13,370

12,269

12,447

Share based payment reserve

 

112

67

112

Merger reserve

 

1,012

1,833

1,012

Retained earnings

 

(12,840)

(11,293)

(12,250)

Total Equity

 

4,450

5,643

4,088

 

Condensed consolidated statement of changes in equity

For the 6 months ended 30 June 2024

 

 

Share capital

Share premium

Share based payments reserve

Merger Reserve

Retained Earnings

Total Equity

 

£’000

£’000

£’000

£’000

£’000

£’000

 

 

 

 

 

 

 

Balance at 1 January 2023

2,688

8,385

51

1,012

(10,909)

1,227

 

 

 

 

 

 

 

Loss for the year

-

-

-

-

(1,341)

(1,341)

Other comprehensive income – issue of broker warrants

-

-

61

-

-

61

Total comprehensive expense for the year

-

-

61

-

(1,341)

(1,280)

 

 

 

 

 

 

 

Contributions by and distributions to owners

 

 

 

 

 

 

Issue of shares net of transaction costs

79

4,062

-

-

-

4,141

Total contributions by and distributions to owners

79

4,062

-

-

-

4,141

 

 

 

 

 

 

 

Balance at 31 December 2023

2,767

12,447

112

1,012

(12,250)

4,088

Loss for the year

-

-

-

-

(590)

(590)

Issue of shares net of transaction costs

29

923

-

-

-

952

Balance at 30 June 2024

2,796

13,370

112

1,012

(12,840)

4,450

 

 

 

 

 

 

 

Condensed consolidated statement of cash flows

For the 6 months ended 30 June 2024

 

 

Unaudited 6 months to 30 June 2024

Unaudited 6 months to 30 June 2023

Audited 12 months to December 2023

 

£’000

£’000

£’000

Cashflows from operating activities

 

 

 

(Loss) before taxation

(634)

(384)

(1,341)

Adjustments for:

 

 

 

Depreciation and amortisation

81

63

137

Fair value adjustments for listed investments

37

73

61

Share based payments

-

(25)

61

R&D tax rebate received

44

-

-

Decrease/(Increase) in trade and other receivables

932

(544)

(823)

Increase in trade and other payables

355

2,059

898

Subsidiary working capital movement on acquisition

-

(1,849)

-

Net cash used in operating activities

815

(607)

(1,007)

 

 

 

 

Cashflows from investing activities

 

 

 

Purchase of tangible fixed assets

(5)

-

(3)

Additions to intangible fixed assets

(6)

-

-

Purchase of investments in subsidiaries, net of cash acquired

-

-

(500)

Cash acquired on acquisition

-

-

331

Net cash flows from investing activity

(11)

-

(172)

 

 

 

 

Cash flows from financing activities

 

 

 

Cash raised through issue of shares (net of transaction costs)

951

878

1,057

Net cash flow from financing activity

951

878

1,057

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

1,755

271

(122)

Cash and cash equivalents at beginning of financial year

100

222

222

Cash and cash equivalents at the end of financial year

1,855

493

100

 

 

  1. General information

Acuity RM Group plc (previously Drumz plc) is a company incorporated and domiciled in the United Kingdom. The Company is a public limited company, which is listed on AIM of the London Stock Exchange, incorporated and domiciled in England and Wales. The address of the registered office is 2nd Floor, 80 Cheapside, London EC2V 6EE.  The condensed consolidated interim financial report was approved for issue by the Board of Directors on 16 September 2024.

 

The Company successfully completed the acquisition of Acuity Risk Management Limited (“Acuity RM”), in which it previously held a 25% investment, on 25 April 2023 and changed its name to Acuity RM Group plc.

 

The principal activity of the Group is the provision of risk management software, STREAM® and related services.

 

The financial information set out in this interim financial report does not constitute statutory accounts as defined in Sections 434(3) and 435(3) of the Companies Act 2006. The Company’s statutory financial statements for the year ended 31 December 2023 have been filed with the Registrar of Companies and are available at www.acuityrmgroup.com. The auditor’s report on those financial statements was unqualified and did not contain any statement under Section 498(2) or Section 498(3) of the Companies Act 2006.

 

2. Basis of preparation

The condensed consolidated interim financial report has been prepared in accordance with the requirements of the AIM Rules for Companies using accounting polices expected to be adopted for the year ending 31 December 2024.

 As permitted, the Company has chosen not to adopt IAS 34 “Interim Financial Statements” in preparing this interim financial information. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2023. The interim financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the United Kingdom. (“UK adopted IFRS”) and those parts of the Companies Act 2006 applicable to companies reporting in accordance with UK adopted IFRS.

The comparative figures for the financial year ended 31 December 2023 set out in these interim statements are not the Group’s statutory accounts for that financial year. Those accounts have been reported on by the Company’s auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

 

Going concern

The Directors, having made appropriate enquiries, consider that adequate resources exist for the Company and Group to continue in operational existence for the foreseeable future and that, therefore, it is appropriate to adopt the going concern basis in preparing the condensed consolidated interim financial statements for the period ended 30 June 2024.

Risks and uncertainties

The Board continuously assesses and monitors the key risks of the business. The key risks that could affect the Group’s medium-term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company’s 2023 Annual Report and Financial Statements, a copy of which is available on the Company’s website: www.acuityrmgroup.com.

Critical accounting estimates

The preparation of condensed consolidated interim financial report requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the end of the reporting period. Significant items subject to such estimates are set out in the Company’s 2023 Annual Report and Financial Statements. The nature and amounts of such estimates have not changed significantly during the interim period.

 

3. Accounting policies

Except as described below, the same accounting policies, presentation and methods of computation have been followed in these condensed consolidated interim financial statements as were applied in the preparation of the Group’s annual financial statements for the year ended 31 December 2023.

 

 

 

 

 

 

 

3.1 Changes in accounting policy and disclosures

(a) Accounting developments during 2024

The International Accounting Standards Board (IASB) issued various amendments and revisions to International Financial Reporting Standards and IFRIC interpretations. The amendments and revisions were applicable for the period ended 30 June 2024 but did not result in any material changes to the financial statements of the Group or Company.

Standard  

Impact on initial application

Effective date

IAS 1

Non-current liabilities with covenants

1 January 2024

IAS 1

Classification of Liabilities as Current or Non-Current.

1 January 2024

IFRS 16

Lease liability in a sale and leaseback

1 January 2024

IAS 7 and IFRS 7

Supplier finance arrangements

1 January 2024

IAS 21

Lack of exchangeability

1 January 2024

 

 

 

(b) New standards, amendments and interpretations in issue but not yet effective or not yet endorsed and not early adopted

The Group is evaluating the impact of the new and amended standards above which are not expected to have a material impact on the Group’s results or shareholders’ funds.

4. Loss per ordinary share

The loss per ordinary share is based on the weighted average number of ordinary shares in issue during the period of 123,461,493 ordinary shares of 0.1p (2023: 70,042,357 ordinary shares of 0.1p). (2023 was adjusted for share reorganisation 24 April 2023).

 

Unaudited 6 months to 30 June 2024

Unaudited 6 months to 30 June 2023

Audited year to 31 December 2023

Loss attributable to equity shareholders £’000

(590)

(384)

(1,341)

Loss per ordinary share

(0.48)p

(0.55)p

(1.39)p

 

There was a consolidation and subdivision of the ordinary shares of 0.1p on 24 April 2023 following that exercise the number of shares was reduced on the basis of 1 for 10.  All share numbers and loss per share have been adjusted to reflect the change.

Diluted loss per share is taken as equal to basic loss per share as the Company’s average share price during the period is lower than the exercise price and therefore the effect of including share options is anti-dilutive.

5. Revenue and segmental analysis

The following is an analysis of the Group’s revenue for the period from continuing operations:

 

 

Unaudited 6 months to 30 June 2024

Unaudited 6 months to 30 June 20231

Audited year to 31 December 20231

 

£’000

£’000

£’000

Fees and Income from investee companies

-

20

15

 

 

 

 

Provision of software licences and services consisting of:

1,049

327

1,351

 

 

 

 

Revenue from subscriptions

900

299

1,114

Revenue from services

149

28

237

 

1 The comparatives include the subsidiary, Acuity Risk Management Limited, from date of acquisition, 25 April 2023.

 

 

 

 

 

 

 

 

 

 

 

 

 

6. Intangible Assets

 

Software development

Other Intangibles

Goodwill Acquired on acquisition

Total

 

£’000

£’000

£’000

£’000

Cost or valuation

 

 

 

 

B/f at 1 January 2024

670

264

5,154

6,088

Additions

6

-

-

6

Asset reclass 1

-

(264)

-

(264)

C/f at 30 June 2024

676

-

5,154

5,830

 

 

 

 

 

Accumulated amortisation

 

 

 

 

B/f at 1 January 2024

437

264

-

701

Charge for period

78

-

-

78

Asset re-class1

-

(264)

-

(264)

C/f at 30 June 2024

515

-

-

515

 

 

 

 

 

Net book value as 30 June 2024

161

-

5,154

5,315

 

 

 

 

 

Net book value as 30 June 2023

353

22

5,829

6,204

 

 

 

 

 

Net book value as 31 December 2023

233

-

5,154

5,387

 

1 Asset re-class relates to intangible assets which were fully amortised at 31 December 2023, (net book value was zero), and are no longer in use. The cost and the accumulated depreciation have been netted down.

 

 

 

 

 

 

 

 

 

7. Share Capital

At the 30 June 2024 the Company’s share capital was as follows:

Allotted, issued and fully paid

Number

Value £

 

 

 

Ordinary shares of 0.1p each

150,128,159

150,128

Deferred share of 0.1p each

2,645,945,765

2,645,946

 

 

 

Total

 

2,796,084

 

As at 31 December 2023 the number of ordinary shares was 121,556,731. On 17 June 2024 the Company issued 28,571,428 ordinary 0.1p shares at a price of 3.5p each raising an additional £1.0m gross of costs.

The value of the deferred shares shown in note 7 is nominal, they are effectively valueless following the approval by Ordinary and Deferred shareholders of resolutions to adopt new articles of association in November 2022.

8. Investment

The Company acquired its legacy investment in KCR Residential REIT plc (“KCR”) at a price of £0.70 per share in 2018. KCR is an AIM listed real estate investment trust focused on the residential property market. The investment was classed as fair value through profit and loss in accordance with IFRS 9. The share price at 30 June 2024 was £0.09 per share and the closing value at 30 June 2024 was £207,205. (31 December 2023: £243,571 and 30 June 2023: £232,000). The investment was valued downwards at 30 June 2024 by £36,366 in accordance with IFRS 13.

As KCR is an AIM listed company, it is measured under level 1 of the fair value hierarchy in accordance with IFRS 13:

-          Level 1: quoted prices in an active market for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is regarded as active if quoted prices are readily and regularly available and those prices represent actual and regularly occurring market transactions on an arm’s-length basis. The quoted market price used for financial assets held by the Group is the closing price on the last day of the financial year of the Group. These instruments are included in level 1 and comprise FTSE and AIM-listed investments classified as held at fair value through profit or loss.

All assets held at fair value through profit or loss were designated as such upon initial recognition.

 




1 Year Acuity Rm Chart

1 Year Acuity Rm Chart

1 Month Acuity Rm Chart

1 Month Acuity Rm Chart